Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-10
1987-06-23
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 67, A61K 3148
Patent
active
046753222
ABSTRACT:
N-1-substituted-6-n-propyl-8.beta.-methylthio-methylergoline, D-2 agonists without interaction with alpha adrenergic receptors.
REFERENCES:
patent: 3901894 (1975-08-01), Kornfeld
patent: 4166182 (1979-08-01), Kornfeld
patent: 4180582 (1979-12-01), Kornfeld
patent: 4202979 (1980-05-01), Kornfeld
patent: 4246265 (1981-01-01), Kornfeld
patent: 4348391 (1982-09-01), Stutz et al.
patent: 4348392 (1982-09-01), Fehr et al.
patent: 4563461 (1986-01-01), Cohen et al.
Smidrkal, et al., "I Subtitled Ergoline Derivatives," Chem Abst. 96:143148X.
Fuller et al., Life Sci, 24, 375 (1979).
Barclay Bruce J.
Eli Lilly and Company
Rizzo Nicholas S.
Shen Cecilia
Whitaker Leroy
LandOfFree
1-Substituted-6-n-propyl-8.beta.-methylthio-methylergolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Substituted-6-n-propyl-8.beta.-methylthio-methylergolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Substituted-6-n-propyl-8.beta.-methylthio-methylergolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-721389